What are the milestones for HER2 Gals?
Comments
-
Thanks!! That was excellent. It makes me think my stats are pretty good. I did TCH and still doing herceptin.
-
Bluedasher, I am ER/PR+ and HER2- I had Papillary Carcinoma which is so rare they just say IDC. What are my risks?
-
I don't know anything about Papillary Carcinoma and I mostly focus on the risks for HER2+. Risk also depends a lot on the size of the invasive tumor if there was one and on whether any nodes were involved.
HER2-, hormone positive often doesn't need chemo. It is much less likely to recur. I gave the numbers from the MD Anderson study for HER2-, hormone positive node negative IDC tumors less than 1 cm without chemo in my response to you earlier in this thread. DFS was 95% - i.e. probably about as good as I get for going through chemo and Herceptin with a 1 cm node negative tumor.
You will probably find people more knowledgeable about HER2- hormone+ on the part of the forum for that.
-
There isn't a forum for HER2-, but thanks for the info!
-
I have a question. It might be hard for me to articulate clearly. It is about recurrances. And thank you in advance for help and answers.
Ok so let's say someone starts chemo and herceptin in January 2010 (for sake of this example). They finish chemo in April. They continue on Herceptin only until January 2011. Would their 3 year highest-risk window be Jan 2010-2011-2012, concluding Dec of 2012? (Obviously I know that nothing final and formal concludes at that date, but I am just trying to get an understanding of what the window is.)
Now, someone earlier on this thread said she was getting 2 years of Herceptin. Would that extend out her 3 year recurrance window another year (through 2013 in the example above), or would she be extra-protected during the first 2 of the 3 year window? I mean, if that is so, why couldn't we stay on herceptin for the whole 3 years?
I was considering the neratinib trial which is a year after herceptin concludes - and my reason was that it would fill another year of the 3 year window with me having a potentially preventative medicine. The research onc that interviewed me seemed to say that the three years of highest risk for recurrance were AFTER treatment stopped, at which point it would be most likely the cancer might reoccur once your body was 'on its own.' She said that if that was my main reason, I was only prolonging the time before I had to accept being at the end of treatment and seeing what happened. With that in mind, I thoughtfully concluded that the trial was not right for me.But this is just very confusing.
Does my question make sense? It would seem also that IF the three years is the most highest risk time for recurrance, that it would be the time to be most diligent about maintaining any lifestyle changes (re alcohol, weight management, supplements, diet etc). Would that seem true?
Thanks again to anyone who can help me make sense of this.Amy
-
I also wonder why Herceptin is not continued for longer if it helps...aren't they going 10 years now?
-
Barbe, sorry, I didn't realize that there is a triple negative forum and a HER2+ forum but no hormone positive HER2- one - I guess that is because it is the main stream diagnosis (most common and least agressive). You could try the IDC forum since they lump your cancer in with that or the hormone therapy forum.
Amy, the trials usually measure from the start of therapy. A treatment might delay recurrence if it is interfering with the ability of the cancer to grow and reproduce but not killing it. But if it is killing it off well, then the benefit should be long term. I think that Herceptin treatment is more like the second one - in combination with chemo, it usually kills the cancer cells.
There is no evidence that extending the Herceptin provides increased protection for non-metastatic cancer. One theory says that Herceptin helps kill off most HER2+ cells but that in some cases there are ones that are resistant to it. At the end of the year, it has probably gotten all the cells that it is going to. If you have resistant cells another year won't help. In Europe they often only do Herceptin for 18 weeks and even that seems to get good results.
An alternate theory is that Herceptin sometimes holds some HER2+ cells from multiplying but that it doesn't kill them off. If that was the case, continuing Herceptin might delay recurrence.
There is a large study comparing three arms: control without Herceptine versus one and two years of Herceptin, HERA. It started in 2001. They have only relaeased data comparing control and 1 year of Herceptin arms showing the advantage of using Herceptin over not having it. They haven't released data on the 2 year arm. I think that if they had found improved DFS or survival in the 2 year arm, they would have released that data. Not having published anything probably means that they have not yet found any significant difference between 1 and 2 years of Herceptin. Therefore, I think that the first theory is more applicable and we wouldn't benefit from an extra year.
For metastic cancer, they sometimes do continue Herceptin long term. My simplistic understanding is that once cancer is metastatic there can be cells hiding in places where the drugs can't get to it as well so they often continue therapy as long as it is going well. Herceptin is usually well tolerated, but there can be side effects and occasionally heart damage though it appears that that heals when Herceptin is stopped. (And it is also a very expensive drug still.) They aren't going to do 2 years of Herceptin for stage I, II and III if there is no demonstrated advantage because there is the potential of harm from side effects and because of the expense.
-
Amy, I think there are two reasons why Neratinib might be helpful after Herceptin. As I mentioned, a small amount of HER2+ cancers are resistant to Herceptin. Neratinib might act against those. Also Neratinib is smaller and supposed to be able to penetrate the blood brain barrier so if there are any cells that have made it to the brain, Herceptin won't help and Neratinib might.
I thought about trying to join the Neratinib trial but I read about the bad diarrhea some were having on that trial. I had a lot of trouble with that when I tried the bisphosponate trial and had to drop out of it due to that and high creatinine levels. At stage I, I decided that the possible slight improvement of Neratinib wasn't worth the health risks of being on the trial for me.
-
One more thing to remember for those of us gals that don't fully respond to the Herceptin. If you should have a recurrence, you will get herceptin again, but you should also request Tykerb. Tykerb works like neratinib (I was in the neratinib trial) and herceptin, but it is a dual her1 and her2 blocker. It crosses the barrier to the brain. It is an oral medicine that is usually used when the patient doesn't respond fully to herceptin.
I originally did TCH, but apparently my cancer didn't go away completely and started to grow back. I am now almost done with A/C TH with Tykerb. My doctor told me that Her2 cancer doesn't like Taxol. Fortunately, I DO like Taxol because it is a much easier regimen to tolerate.
I wish you all continued health.
Hugs,
Anne
-
Just to be clear, are we counting milestones from the date we started treatment? Is that what most oncologists do when they speak of us reaching the three or five year mark?
-
AnneMarie, if you go back to the graph posted on page 1 of this thread above, it seems that "years from surgery" are used as a marker, not years from starting chemo etc. This makes sense because everyone with every type of BC will receive surgery, but after this it varies. Not everyone will have adjuvant treatment - the low risk BC patients will have nothing further at all.
Hugs,
Lucy
-
Tykerb (along with Xeloda) kicked my cancer's butt. Something that Adriamycin, Cytoxin, Taxol, Herceptin and radiation could not do. I had a recurrence while still taking Herceptin and while in the middle of radiation. But, the Tykerb and Xeloda have put me into remission. I am no longer taking Xeloda (took it from July 2009 - January 2010) but still take 1500mg daily of Tykerb and will indefinitely.
-
Hi Anne Marie,
I had 4 cycles of Adriamycin and Cyclophosphamide and 4 cycles of Taxotere in conjunction with Herceptin. I will have Herceptin for a total of 18 treatments. I was diagnosed in Nov. 2009 with Stage 3, grade 3, ER/PR negative Her2neu positive cancer with 2 nodes positive. I had a double mastectomy with lymph node removal on June 18th. I got word 2 weeks ago that the post-op pathology report shows that there is no sign of any cancer in either breast or in my lymph nodes. My Oncologist has told me that my prognosis is "excellent" and that the chance of recurrance is 25% in 20 years.
Hope that helps.
-
I had TCH x6. Chemo first. At surgery, nothing left of cancer. Complete Chemo response. BS said I reacted the way about 15% of people do to chemo, with complete response. Also said my body acted like a stage I would to treatment vs the stage II that I was. Also said that increased my long term survival, and further decreased my change for re-occurrence. I was so happy to hear that I didin't ask anymore questions.
Still on herceptin, 10 out of 18 done, 8 more to go.
-
Annemarie -- I too am hormone negative, HER2+ and thanks for this thread. I had two lumpectomies, then chemo (ACT and H for a year); uni-MX followed a month after completing ACT. No cancer at all in remaining breast tissue. Guess I will count my first three years from date of surgery (since that is a demonstrable moment of NED). I have three more Herceptins to go!
Thanks everyone for the really smart, helpful information.
-
Stlcardsfan: Wish I could have done chemo before my mastectomy to know what my response would be, but at the time of my bilateral mastectomy everyone thought I only had DCIS. It wasn't until after the pathology was done for the entire breast tissue that the IDC was discovered. I can imagine what a relief it must be to have tangible proof that the chemo is working. Also, congrats on only having 8 more Herceptin treatments to go. I'll be taking Herceptin every three weeks until March of 2011.
Lilah: Im curious, no radiation for you? Here the usual protocol for any positive lymph nodes is radiation.
-
I will have the 6 year anniversary of being NED in Oct 2010. Dx 9/04 and started treatment in10/04. ER-, Pr-, Her2+. 30+ positive lymph nodes. Had L mast, 4 AC, 4 Cytox, Rads, 1 year hercept, and a trial Her2 vaccine. Feel like I am a miracel and am greatful for every day.
-
Barbe Many folks build up a resistance to herceptin especially after 1 year so taking it longer is ineffective. Also Herceptin can be rough on the heart (congestive heart failure) which is increased if you were also treated with Adriamycin and Cytoxan.
-
Billiegirl - my dx is just like yours with less positive nodes, but still too many in my book. I am so glad to hear you are doing well so far out from DX.
-
Way to go Billiegirl - that is awesome!
-
lago - so true about the heart problems from herceptin (or combination of both adriamycin and herceptin) as my ejection fraction went down to 25% after 6 months of herceptin. With eating right and walking at least 5 miles a week on my treadmill and a few heart meds, I have built my ejection fraction back up to 45% luckily. The onc and cardiac doc decided together that I should not go back on herceptin. I finally got past that and am happy that I got 6 months of herceptin before the problem developed.
-
Annemarie -- I think because it was only 1 node and I was 49 at time of DX that radiation was not considered necessary for me. I did have chemo and herceptin. And there was no evidence of disease in the tissue they removed (post chemo) when I had my MX. From what I understand the radiation when 1 node is positive is usually for those with lumpectomy or those who are very young at time of DX (like under 45). You're not the first person to say this to me though so I think I'll question my ONC again!
Billiegirl -- wahoooo and good for you!!!!
-
Lilah: Ah, the age aspect seems to make sense (I guess). I suppose most women with one positive node that come to my mind are those in their thirties, since I participate in a young survivors support group, and they all had rads.
Billiegirl: My goodness! You rock! You are indeed a miracle and an inspiration! I'm glad you stopped by and shared your history with us.
-
I have not been on this forum for a while because of vacation and other plans.
To go back to the original question about recurrence risk for ER/PR-, HER2+ BC, this is what I have picked up from various studies over the years. I am only going to summarize and I can not provide the studies themselves.
For ER/PR-, Her2+ Stage 1 IDC treated with chemotherapy and 1 year of herceptin, the highest possibility of recurrence is the 1 -2 years following the completion of the chemotherapy (the one year is the year that the herceptin is given so if you recur during herceptin treatment, it is not good!!). Two years recurrence free is good news for ER/PR-, HER2+ BC. The risk starts to decline in the third year and basically flattens out in year 4 -5.
There has also been a study that shows the positive benefits of the herceptin treatment disappears somewhere after year 3 -4. After that the hormonal status takes over for risk. So a ER/PR-, HER2+ BC has the risk of a triple negative after years 3 -4.
This is very good for us ER/PR-, HER2+ patients. Triple negative recurrence risk is basically at zero by year 5 and can be considered "cured" at year 8 if there is no other indication of active disease.
-
Thanks, Sassa, that's all very clear and succinct--wonderful!--and seems consistent with the studies posted earlier in this thread.
-
Billiegirl..great news and gives me hope,since I am er/pr - her2 +,and had 31 pos.nodes(which freaked me out).Although my pet scan was clear.Just finished herceptin.!
-
I wanted to add my experience, as I know it is not usual, but I think it shows you need to be vigil no matter how far out you are.
I was diagnosed 3/21/05. Had mast on 3/24 and began chemo April14. age 37 er/pr - Her2+++, 4.5 cm and 2+ nodes. Did ac, taxol/herceptin, then herceptin for a year, finishing in May of 2006. I had my five year check up with my onc, who let me go and said just have yearly check ups with family dr. He told me my risk was as close to zero as you could get.
about a month ago, I started having severe pain in my back and pain when breathing in. I finally went to the ER, where I found out that I had a 11 cm tumor on my liver. It was breast cancer, same kind (er/pr her2+++)
It's hard not questioning if I could have been given doses of herceptin occassionally, if this could have been prevented. I am happy that I was NED for as long as I was. My youngest daughter was 2 when I was diagnosed, and now she is 8. I hope to be here until she is at least 18, if not longer.
I would also say try not to worry if it is 2, or 3 years or 4 years when you are "safe", You will never know. Live your life, enjoy every year, find happiness every day with your family and friends.
-
Does anyone know of any studies done for patients who had chemo/herceptin to treat early stage bc??? I'm five years out now and while we can never say never again, it would be comforting to know if we can relax a little at this stage!
Tricia x
-
Tricia
I am with you, I would like to know as well. Both my Onc's say with aggressive Her2 grade 3 you should recur in first 3 years and then fine. Certainly by year 5 all should be good. However there is Laurie's story above and I guess we just don't know. Laurie what does your ONC say about this especially since you were given such a green light at 5 year check up. I pray that Herceptin puts you right back to NED condition.
-
what did my onc say? He didn't say much. He shook his head and said we just don't know. Obviously the risk is not zero at any point. There is another woman (same pathology, same treatment ) who I met at a young survivor's group who recurrred at about 5 1/2 years.
Obviously the risk goes down, but I now believe that it is never at zero.
Laurie
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team